Adaptimmune Therapeutics (ADAPY)
OTHER OTC:ADAPY
Want to see ADAPY full AI Analyst Report?
Technical Sentiment
Overall Consensus
Buy
12Bullish
2Neutral
8Bearish
Technical Analysis Consensus
Sell
2Bullish
2Neutral
6Bearish
Moving Average Consensus
Strong Buy
10Bullish
0Neutral
2Bearish
Adaptimmune Therapeutics’s (ADAPY) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting Adaptimmune Therapeutics is a Sell.
Adaptimmune Therapeutics’s (ADAPY) 20-Day exponential moving average is 0.03, while Adaptimmune Therapeutics’s (ADAPY) share price is <$0.1, making it a Buy.
Adaptimmune Therapeutics’s (ADAPY) 50-Day exponential moving average is 0.02, while Adaptimmune Therapeutics’s (ADAPY) share price is <$0.1, making it a Buy.
Adaptimmune Therapeutics (ADAPY) Pivot Points
Classic
<0.01
0.02
0.02
0.03
0.04
0.05
0.05
Fibonacci
0.02
0.02
0.03
0.03
0.04
0.04
0.05
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.
Adaptimmune Therapeutics (ADAPY) Moving Averages
MA5
0.03Buy
0.03Buy
MA10
0.03Buy
0.03Buy
MA20
0.02Buy
0.03Buy
MA50
0.02Buy
0.02Buy
MA100
0.03Buy
0.03Buy
MA200
0.06Sell
0.07Sell
Adaptimmune Therapeutics’s (ADAPY) 10-Day exponential moving average is 0.03, while Adaptimmune Therapeutics’s (ADAPY) share price is <$0.1, making it a Buy.
Adaptimmune Therapeutics’s (ADAPY) 100-Day exponential moving average is 0.03, while Adaptimmune Therapeutics’s (ADAPY) share price is <$0.1, making it a Buy.
Adaptimmune Therapeutics’s (ADAPY) stock price is <$0.1 and Adaptimmune Therapeutics’s (ADAPY) 50-day simple moving average is 0.02, creating a Buy signal.
Adaptimmune Therapeutics’s (ADAPY) stock price is <$0.1 and Adaptimmune Therapeutics’s (ADAPY) 100-day simple moving average is 0.03, creating a Buy signal.
Adaptimmune Therapeutics’s (ADAPY) stock price is <$0.1 and Adaptimmune Therapeutics’s (ADAPY) 200-day simple moving average is 0.06, creating a Sell signal.
Adaptimmune Therapeutics (ADAPY) Technical Indicators
RSI (14)
71.55
Sell
STOCH (9,6)
80.84
Sell
STOCHRSI (14)
82.46
Sell
MACD (12,26)
<0.01
Sell
ADX (14)
24.45
Neutral
Williams %R
-2.63
Sell
CCI (14)
136.90
Sell
ATR (14)
0.01
-
Ultimate Oscillator
66.01
Neutral
ROC
100.00
Buy
Adaptimmune Therapeutics’s (ADAPY) Relative Strength Index (RSI) is 71.55, creating a Sell signal.
Adaptimmune Therapeutics’s (ADAPY) Trend Strength Indicator (ADX) is 24.45, creating a Neutral signal.
Adaptimmune Therapeutics’s (ADAPY) Commodity Channel Index (CCI) is 136.90, creating a Sell signal.
Adaptimmune Therapeutics’s (ADAPY) Price Rate of Change (ROC) is 100.00, creating a Buy signal.
FAQ
Is ADAPY a Buy, Hold, or Sell?
Based on ADAPY’s technical indicators, ADAPY is a Buy.
What is ADAPY’s RSI (14)?
ADAPY’s RSI (14) is 71.55, which suggests ADAPY is a Sell.
What is ADAPY’s MACD?
ADAPY’s MACD is <0.01, which suggests ADAPY is a Sell.
What is ADAPY’s 5-day moving average?
ADAPY’s 5-day moving average is 0.03, which suggests ADAPY is a Buy.
What is ADAPY’s 20-day moving average?
ADAPY 20-day moving average is 0.02, which suggests ADAPY is a Buy.
What is ADAPY’s 50-day moving average?
ADAPY’s 50-day moving average is 0.02, which suggests ADAPY is a Buy.
What is ADAPY’s 200-day moving average?
ADAPY’s 200-day moving average is 0.06, which suggests ADAPY is a Sell.
What is ADAPY’s Williams % R (14)?
ADAPY’s Williams % R (14) is -2.63, which suggests ADAPY is a Sell.
What is ADAPY’s CCI (14)?
ADAPY’s CCI (14) is 136.90, which suggests ADAPY is a Sell.